이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Advanced Enzyme Technologies 대차 대조표 상태
재무 상태 기준 확인 6/6
Advanced Enzyme Technologies 의 총 주주 지분은 ₹13.7B 이고 총 부채는 ₹251.1M, 이는 부채 대 자기자본 비율을 1.8% 로 가져옵니다. 총자산과 총부채는 각각 ₹15.4B 및 ₹1.6B 입니다. Advanced Enzyme Technologies 의 EBIT는 ₹1.7B 이며 이자보상배율은 57.8 입니다. ₹5.5B 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
1.8%
부채 비율
₹251.12m
부채
| 이자 보상 비율 | 57.8x |
| 현금 | ₹5.46b |
| 주식 | ₹13.71b |
| 총 부채 | ₹1.64b |
| 총 자산 | ₹15.35b |
최근 재무 상태 업데이트
Recent updates
Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00
Jul 13
Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business
Apr 08Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Sep 23Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital
Feb 03Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Aug 11With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting
May 13Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture
Mar 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?
Mar 13Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
Feb 21Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 18I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut
Feb 03
What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?
Jan 19What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?
Dec 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?
Dec 13Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Nov 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?
Nov 20Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today
Nov 05What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition
Oct 21Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Oct 06Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stocks Shoot Up 31% But Its P/E Still Looks Reasonable
Sep 26Our Take On The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES)
Sep 21Does Advanced Enzyme Technologies (NSE:ADVENZYMES) Have A Healthy Balance Sheet?
Sep 08Have Insiders Sold Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Recently?
Aug 26Why We're Not Concerned About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Share Price
Aug 21Introducing Advanced Enzyme Technologies (NSE:ADVENZYMES), A Stock That Climbed 60% In The Last Year
Aug 20Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) P/E Is On The Mark
Aug 07재무 상태 분석
단기부채: ADVENZYMES 의 단기 자산 ( ₹8.1B )이 단기 부채( ₹1.1B ).
장기 부채: ADVENZYMES 의 단기 자산( ₹8.1B )이 장기 부채( ₹580.3M ).
부채 대 자본 내역 및 분석
부채 수준: ADVENZYMES 총 부채보다 더 많은 현금을 보유하고 있습니다.
부채 감소: ADVENZYMES 의 부채 대 자기자본 비율은 지난 5년간 4.9% 에서 1.8% 로 감소했습니다.
부채 범위: ADVENZYMES 의 부채는 영업 현금 흐름 ( 563% )에 의해 잘 충당되었습니다.
이자 보장: ADVENZYMES 의 부채에 대한 이자 지급은 EBIT( 57.8 x 적용 범위)로 잘 충당됩니다.